0.547 0.034 (6.52%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 1.37 | 1-year : | 1.86 |
Resists | First : | 1.17 | Second : | 1.6 |
Pivot price | 0.59 ![]() |
|||
Supports | First : | 0.49 | Second : | 0.41 |
MAs | MA(5) : | 0.55 ![]() |
MA(20) : | 0.64 ![]() |
MA(100) : | 0.59 ![]() |
MA(250) : | 1.77 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 10.3 ![]() |
D(3) : | 11.4 ![]() |
RSI | RSI(14): 43.7 ![]() |
|||
52-week | High : | 7.18 | Low : | 0.37 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HSDT ] has closed above bottom band by 30.7%. Bollinger Bands are 21.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.56 - 0.56 | 0.56 - 0.56 |
Low: | 0.51 - 0.52 | 0.52 - 0.52 |
Close: | 0.54 - 0.55 | 0.55 - 0.55 |
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Fri, 07 Feb 2025
Helius Medical faces Nasdaq delisting over bid price - Investing.com
Fri, 07 Feb 2025
Helius Medical Technologies Inc - Continues Non-Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com
Tue, 21 Jan 2025
Helius Medical Raises $3.7M Through Warrant Exercise at $0.751, Issues New Warrants - StockTitan
Tue, 21 Jan 2025
Helius Medical Surpasses Stroke Trial Enrollment Goals for Revolutionary PoNS Device - StockTitan
Mon, 18 Nov 2024
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives - GlobeNewswire
Mon, 18 Nov 2024
Helius Medical (HSDT) Explores Strategic Sale Options Amid Reimbursement Challenges - StockTitan
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 4 (M) |
Held by Insiders | 3.56e+006 (%) |
Held by Institutions | 0.5 (%) |
Shares Short | 59 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.183e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -1 % |
Return on Assets (ttm) | 796.7 % |
Return on Equity (ttm) | -76.1 % |
Qtrly Rev. Growth | 594000 % |
Gross Profit (p.s.) | -17.96 |
Sales Per Share | -100.61 |
EBITDA (p.s.) | 47205 |
Qtrly Earnings Growth | -4.3 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -10 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.01 |
Price to Cash Flow | 0.26 |
Dividend | 0 |
Forward Dividend | 225380 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |